Showing 1021-1030 of 1347 results for "".
Ophthalmic Ointment for DED Moving Toward NDA Submission
https://modernod.com/editorial-series/significant-findings/ophthalmic-ointment-for-ded-moving-toward-nda-submission/49220/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all cuThe Changing Paradigm of Interventional Glaucoma
https://modernod.com/mod-issues/2025-jan-feb/the-changing-paradigm-of-interventional-glaucoma/39803/An overview of the different procedures that fall under this classification, how they differ from and complement each other, and a peek at what’s to comeWatch for Complications of Systemic Meds
https://beta.modernod.com/articles/significant-findings/watch-for-complications-of-systemic-meds/39848/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatGaining Insights Into POAG
https://modernod.com/articles/significant-findings/gaining-insights-into-poag/37774/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatPotential Treatment Found for Age and Diabetes-Induced Eye Disease
https://modernod.com/articles/significant-findings/potential-treatment-found-for-age-and-diabetes-induced-eye-disease/37735/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatDrug Shortages Due to Dual Indications
https://modernod.com/articles/significant-findings/drug-shortages-due-to-dual-indications/37738/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatFDA Flags Improperly Marketed Amniotic Fluid Eye Drops
https://modernod.com/articles/significant-findings/fda-flags-improperly-marketed-amniotic-fluid-eye-drops/37734/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatArtificial Tear Brand Linked to Eye Infections
https://modernod.com/articles/significant-findings/artificial-tear-brand-linked-to-eye-infections/37721/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatMaking Headway in the Treatment of a Common Disease
https://modernod.com/topics/glaucoma/making-headway-in-the-treatment-of-a-common-disease/38181/Taking stock of the latest trends in glaucoma diagnosis and treatment.How Do Your Patients Rate You?
https://modernod.com/topics/business/how-do-your-patients-rate-you/38141/Five tips to improve your patients’ experience.